As of 2024-12-13, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is 17.23 USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.15 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -28.7%.
The range of the Relative Valuation is (2.07) - 39.53 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.4x - 38.9x | 35.2x |
| Forward P/E multiples | 28.5x - 31.9x | 30.2x |
| Fair Price | (2.07) - 39.53 | 17.23 |
| Upside | -108.6% - 63.7% | -28.7% |
| Date | P/E |
| 2024-12-11 | -284.75 |
| 2024-12-10 | -283.10 |
| 2024-12-09 | -287.46 |
| 2024-12-06 | -284.16 |
| 2024-12-05 | -281.33 |
| 2024-12-04 | -284.28 |
| 2024-12-03 | -290.41 |
| 2024-12-02 | -289.82 |
| 2024-11-29 | -289.82 |
| 2024-11-27 | -289.35 |
| 2024-11-26 | -279.45 |
| 2024-11-25 | -285.81 |
| 2024-11-22 | -278.03 |
| 2024-11-21 | -271.19 |
| 2024-11-20 | -270.37 |
| 2024-11-19 | -269.78 |
| 2024-11-18 | -265.18 |
| 2024-11-15 | -269.78 |
| 2024-11-14 | -274.38 |
| 2024-11-13 | -274.85 |
| 2024-11-12 | -292.53 |
| 2024-11-11 | -300.08 |
| 2024-11-08 | -292.18 |
| 2024-11-07 | -300.79 |
| 2024-11-06 | -314.82 |
| 2024-11-05 | -293.71 |
| 2024-11-04 | -284.40 |
| 2024-11-01 | -227.33 |
| 2024-10-31 | -221.20 |
| 2024-10-30 | -229.69 |
| 2024-10-29 | -229.92 |
| 2024-10-28 | -227.80 |
| 2024-10-25 | -223.44 |
| 2024-10-24 | -222.61 |
| 2024-10-23 | -225.33 |
| 2024-10-22 | -226.27 |
| 2024-10-21 | -230.04 |
| 2024-10-18 | -234.29 |
| 2024-10-17 | -232.99 |
| 2024-10-16 | -233.46 |
| 2024-10-15 | -230.04 |
| 2024-10-14 | -226.62 |
| 2024-10-11 | -226.74 |
| 2024-10-10 | -227.21 |
| 2024-10-09 | -213.42 |
| 2024-10-08 | -206.22 |
| 2024-10-07 | -205.52 |
| 2024-10-04 | -200.45 |
| 2024-10-03 | -199.86 |
| 2024-10-02 | -204.22 |